Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00908388 · ClinicalTrials.gov registry record · NA
Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00908388 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 50 participants.
The verdict
NCT00908388, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the safety and efficacy of the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) for treatment of subjects with acute complicated type B aortic dissection.
Interventions
- DEVICE GORE TAG® Thoracic Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-10 |
| Est. Completion | 2017-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00908388
The ClinicalTrials.gov registry entry for NCT00908388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE TAG® Thoracic Endoprosthesis is the first listed.
NCT00908388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00908388 about?
NCT00908388 is a clinical study titled "Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection". The primary objective of this study is to determine the safety and efficacy of the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) for treatment of subjects with acute complicated type B aortic dissection.
What is the current status of trial NCT00908388?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-10. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT00908388?
The interventions under investigation include: GORE TAG® Thoracic Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT00908388?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.